Endonovo Therapeutics, Inc. (ENDV): Shareholders' Equity
Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$32.18M
As of 2022-12-31
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | -$32.18M | n/m | 2023-04-17, Balance as of period end |
| 2021-12-31 | -$15.77M | n/m | 2023-04-17, Balance as of period end |
| 2020-12-31 | -$14.37M | n/m | 2022-04-14, Balance as of period end |
| 2019-12-31 | -$20.50M | n/m | 2021-04-13, Balance as of period end |
| 2018-12-31 | -$11.39M | n/m | 2020-05-04, Balance as of period end |
| 2017-12-31 | -$9.55M | n/m | 2019-04-15, Balance as of period end |
| 2016-12-31 | -$8.56M | n/m | 2018-04-06, Balance as of period end |
| 2015-12-31 | -$9.28M | n/m | 2017-04-17, Balance as of period end |
| 2014-12-31 | -$4.69M | n/m | 2016-05-17, Balance as of period end |
| 2013-12-31 | -$4.13M | n/m | 2015-06-15, Balance as of period end |
| 2012-12-31 | -$1.88M | n/m | 2013-05-03, Balance as of period end |
| 2011-12-31 | -$447.2K | n/m | 2013-05-03, Balance as of period end |
| 2010-12-31 | $166.1K | n/a | 2012-04-13, Balance as of period end |